rxstat › Shortages › Cefepime
Cefepime shortage status
Widespread shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Cefepime is in a widespread shortage in Canada. 2 of 3 reported products are affected. The latest manufacturer estimate for full recovery is May 29, 2026.
In shortage since
Aug 23, 2012
Est. full return
May 29, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-CEFEPIME
1G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467496 · since May 12, 2026, est. end May 29, 2026 · Disruption of the manufacture of the drug.
Active shortageCEFEPIME FOR INJECTION
2G · POWDER FOR SOLUTION · APOTEX INC
DIN 02319039 · since Aug 23, 2012, no end estimate · Disruption of the manufacture of the drug.
ResolvedAPO-CEFEPIME
2G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467518 · ended Sep 18, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-CEFEPIME
1G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467496 · ended Feb 13, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-CEFEPIME
1G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467496 · ended Nov 7, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-CEFEPIME
2G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467518 · ended Aug 15, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-CEFEPIME
2G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467518 · ended Jun 20, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-CEFEPIME
1G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467496 · ended Jun 20, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-CEFEPIME
2G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467518 · ended Feb 29, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-CEFEPIME
1G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467496 · ended Feb 7, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-CEFEPIME
1G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467496 · ended Aug 23, 2022 · Disruption of the manufacture of the drug.
ResolvedAPO-CEFEPIME
2G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467518 · ended Oct 22, 2021 · Disruption of the manufacture of the drug.
Showing 12 of 17 reports. All reports are on file with Health Canada.
What's happening
Cefepime is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Cefepime is classified under “OTHER BETA-LACTAM ANTIBACTERIALS” (ATC J01DE).
Recent changes
Common questions
When will Cefepime be back in stock in Canada?
The latest manufacturer estimate is May 29, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Cefepime in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All other beta-lactam antibacterials shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.